Wetzel Investment Advisors, Inc. Viking Therapeutics, Inc. Transaction History
Wetzel Investment Advisors, Inc.
- $194 Million
- Q3 2024
A detailed history of Wetzel Investment Advisors, Inc. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 3,500 shares of VKTX stock, worth $253,890. This represents 0.11% of its overall portfolio holdings.
Number of Shares
3,500
Previous 3,100
12.9%
Holding current value
$253,890
Previous $164,000
34.76%
% of portfolio
0.11%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding VKTX
# of Institutions
460Shares Held
65.6MCall Options Held
6.24MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$732 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$437 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$372 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$163 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$135 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $5.56B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...